| Serial Number | 79402456 |
| Word Mark | EXOPULSE |
| Filing Date | Monday, May 13, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Wednesday, October 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom manufacturing of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications for others; custom manufacture services for others, namely, the rental of machines and apparatus for manufacturing pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications; custom manufacturing consultancy with regard to aforementioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software |
| Goods and Services | Contract new product research and contract new product development in the field of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications; biotechnological and medical research and product development; extracellular vesicles research and development for therapies; culturing of cells and tissues for others for scientific research purposes; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific research and analysis services in the field of extracellular vesicles; biological research; clinical research in the field of extracellular vesicles; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; scientific research in the nature of conducting clinical trials for others; scientific consultancy with regard to aforementioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software |
| Pseudo Mark | EXO PULSE |
| Goods and Services | Extracellular vesicles, namely, exosomes for medical use; extracellular vesicles for clinical use; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; living cells for medical purposes; pharmaceutical preparations and substances, namely, extracellular vesicles for treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, respiratory diseases, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, skin disorders, and hair loss disorders; dermatological preparations; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified extracellular vesicles for therapeutic use; pharmaceutical preparations, namely, extracellular vesicles to deliver protein or RNA for genetic therapy; extracellular vesicles for use in manufacture of pharmaceutical preparations; biological preparations for use in cell cultures for medical purposes; biological preparations comprising extracellular vesicles for medical purposes; biological preparations comprising a therapeutic target protein-loaded extracellular vesiclesfor medical purposes; biological preparations comprising extracellular vesicles for pharmaceutical purposes; biological reagents for medical use; medical preparations for treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, respiratory diseases, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, skin disorders, and hair loss disorders; none of the aforesaid products being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EXO Biologics, Société anonyme |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Event Date | Event Description |
| Thursday, August 15, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, August 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 25, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, December 18, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, December 19, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 10, 2025 | REFUSAL PROCESSED BY MPU |
| Friday, January 10, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, February 1, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, July 9, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 9, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 9, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 8, 2025 | FINAL REFUSAL WRITTEN |
| Wednesday, October 8, 2025 | FINAL REFUSAL E-MAILED |
| Wednesday, October 8, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 24, 2025 | CORRECTION TRANSACTION RECEIVED FROM IB |